Tumor Biology

, Volume 37, Issue 12, pp 15477–15482 | Cite as

RETRACTED ARTICLE: Ginsenoside Rh2 inhibits invasiveness of glioblastoma through modulation of VEGF-A

  • Shaoyi Li
  • Yun Gao
  • Weining Ma
  • Tianci Cheng
  • Yunhui Liu
Research Article


The malignancy of glioblastoma multiforme (GBM) is largely due to its local invasion and the presence of the tumor in the relatively restrained region in the brain. Hence, effective prevention of the cancer cell invasion is substantially critical for controlling the growth and deterioration of GBM. We have recently reported the role of ginsenoside Rh2 (GRh2) in suppressing the growth of GBM through EGFR/PI3k/Akt/mTor signaling pathways. Here, we further showed that GRh2 efficiently inhibited the cancer vascularization in vivo. In vitro, GRh2 dose-dependently inhibited the protein, but not messenger RNA (mRNA) of vascular endothelial growth factor A (VEGF-A) in GBM cells. We then examined the underlying mechanisms and found that GRh2 increased the levels of miR-497, which bound to 3′UTR of VEGF-A mRNA to inhibit its translation. Together, our data demonstrate a previously unappreciated role for GRh2 in inhibition of GBM-associated cancer vascularization, which may contribute to the effects of GRh2 on suppression of GBM cancer growth and invasion.


Glioblastoma multiforme (GBM) Ginsenoside Rh2 (GRh2) Vascular endothelial growth factor A (VEGF-A) miR-497 



This work was supported by the Natural Science Foundation of China (No. 30772246, No. 81072655), Liaoning Provincial Department of Education Science Research Foundation (L2010586), Liaoning Provincial Natural Science Foundation (201202286), and Shengjing Free Researcher Project (2011).

Conflicts of interest



  1. 1.
    Chen J, Huang Q, Wang F. Inhibition of foxo1 nuclear exclusion prevents metastasis of glioblastoma. Tumour Biol. 2014;35:7195–200.CrossRefPubMedGoogle Scholar
  2. 2.
    Wang F, Xiao W, Sun J, Han D, Zhu Y. Mirna-181c inhibits egfr-signaling-dependent mmp9 activation via suppressing akt phosphorylation in glioblastoma. Tumour Biol. 2014;35:8653–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Yu Y, Ran Q. Nuclear smad2 restrains proliferation of glioblastoma. Cell Physiol Biochem. 2015;35:1756–63.CrossRefPubMedGoogle Scholar
  4. 4.
    Gong J, Zhu S, Zhang Y, Wang J. Interplay of vegfa and mmp2 regulates invasion of glioblastoma. Tumour Biol. 2014;35:11879–85.CrossRefPubMedGoogle Scholar
  5. 5.
    Yu X, Jiang Y, Wei W, Cong P, Ding Y, Xiang L, et al. Androgen receptor signaling regulates growth of glioblastoma multiforme in men. Tumour Biol. 2015;36:967–72.CrossRefPubMedGoogle Scholar
  6. 6.
    Eichmann A, Simons M. Vegf signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol. 2012;24:188–93.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473:298–307.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ferrara N, Gerber HP, LeCouter J. The biology of vegf and its receptors. Nat Med. 2003;9:669–76.CrossRefPubMedGoogle Scholar
  9. 9.
    Xiao X, Prasadan K, Guo P, El-Gohary Y, Fischbach S, Wiersch J, et al. Pancreatic duct cells as a source of vegf in mice. Diabetologia. 2014;57:991–1000.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Xiao X, Guo P, Chen Z, El-Gohary Y, Wiersch J, Gaffar I, et al. Hypoglycemia reduces vascular endothelial growth factor a production by pancreatic beta cells as a regulator of beta cell mass. J Biol Chem. 2013;288:8636–46.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Ye H, Wu Q, Zhu Y, Guo C, Zheng X. Ginsenoside rh2 alleviates dextran sulfate sodium-induced colitis via augmenting tgfbeta signaling. Mol Biol Rep. 2014;41:5485–90.CrossRefPubMedGoogle Scholar
  12. 12.
    Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I. Inhibition of human ovarian cancer cell proliferation in vitro by ginsenoside rh2 and adjuvant effects to cisplatin in vivo. Anti-Cancer Drugs. 1991;2:63–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Tode T, Kikuchi Y, Hirata J, Kita T, Imaizumi E. Nagata I: [inhibitory effects of oral administration of ginsenoside rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary]. Nihon Sanka Fujinka Gakkai zasshi. 1993;45:1275–82.PubMedGoogle Scholar
  14. 14.
    Tode T, Kikuchi Y, Kita T, Hirata J, Imaizumi E, Nagata I. Inhibitory effects by oral administration of ginsenoside rh2 on the growth of human ovarian cancer cells in nude mice. J Cancer Res Clin Oncol. 1993;120:24–6.CrossRefPubMedGoogle Scholar
  15. 15.
    Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, et al. Inhibitory effects of ginsenoside rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res. 1998;89:733–40.CrossRefPubMedGoogle Scholar
  16. 16.
    Tang XP, Tang GD, Fang CY, Liang ZH, Zhang LY. Effects of ginsenoside rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol. 2013;19:1582–92.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Liu J, Shimizu K, Yu H, Zhang C, Jin F, Kondo R. Stereospecificity of hydroxyl group at c-20 in antiproliferative action of ginsenoside rh2 on prostate cancer cells. Fitoterapia. 2010;81:902–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, et al. Ginsenoside rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011;301:185–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, et al. Anti-proliferating effects of ginsenoside rh2 on mcf-7 human breast cancer cells. Int J Oncol. 1999;14:869–75.PubMedGoogle Scholar
  20. 20.
    Choi S, Kim TW, Singh SV. Ginsenoside rh2-mediated g1 phase cell cycle arrest in human breast cancer cells is caused by p15 ink4b and p27 kip1-dependent inhibition of cyclin-dependent kinases. Pharm Res. 2009;26:2280–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Li S, Gao Y, Ma W, Guo W, Zhou G, Cheng T, et al. Egfr signaling-dependent inhibition of glioblastoma growth by ginsenoside rh2. Tumour Biol. 2014;35:5593–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Li S, Guo W, Gao Y, Liu Y. Ginsenoside rh2 inhibits growth of glioblastoma multiforme through mtor. Tumour Biol. 2015;36:2607–12.CrossRefPubMedGoogle Scholar
  23. 23.
    Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417–23.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Shaoyi Li
    • 1
  • Yun Gao
    • 2
  • Weining Ma
    • 1
  • Tianci Cheng
    • 1
  • Yunhui Liu
    • 1
  1. 1.Department of NeurosurgeryShengjing Hospital of China Medical UniversityShenyangChina
  2. 2.Center of Molecular PathologyHe UniversityShenyangChina

Personalised recommendations